These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32615708)

  • 1. Epidemiology of Functioning Pituitary Adenomas.
    Chin SO
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):237-242. PubMed ID: 32615708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.
    Ntali G; Wass JA
    Pituitary; 2018 Apr; 21(2):111-118. PubMed ID: 29368293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
    Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
    Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epidemiology of Pituitary Adenomas.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):347-355. PubMed ID: 32741475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
    Iglesias P; Rodríguez Berrocal V; Díez JJ
    Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and etiopathogenesis of pituitary adenomas.
    Aflorei ED; Korbonits M
    J Neurooncol; 2014 May; 117(3):379-94. PubMed ID: 24481996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
    Fernandez A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
    Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
    Dai C; Liang S; Sun B; Kang J
    Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-functioning pituitary adenomas: growth and aggressiveness.
    Øystese KA; Evang JA; Bollerslev J
    Endocrine; 2016 Jul; 53(1):28-34. PubMed ID: 27066792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and incidence of pituitary adenomas.
    Karavitaki N
    Ann Endocrinol (Paris); 2012 Apr; 73(2):79-80. PubMed ID: 22520147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEREDITARY PITUITARY TUMOR SYNDROMES: GENETIC AND CLINICAL ASPECTS.
    García-Guzmán B; Portocarrero-Ortiz L; Dorantes-Argandar AA; Mercado M
    Rev Invest Clin; 2020; 72(1):8-18. PubMed ID: 32132734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies.
    Dai C; Kang J; Liu X; Yao Y; Wang H; Wang R
    Front Endocrinol (Lausanne); 2021; 12():604644. PubMed ID: 33815274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenoma: a radiotherapeutic perspective.
    Platta CS; Mackay C; Welsh JS
    Am J Clin Oncol; 2010 Aug; 33(4):408-19. PubMed ID: 19687730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal.
    Tortosa F; Webb SM
    Neurologia; 2016 Mar; 31(2):97-105. PubMed ID: 26300499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
    Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
    Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of aggressive pituitary tumors (and its challenges).
    Dekkers OM; Karavitaki N; Pereira AM
    Rev Endocr Metab Disord; 2020 Jun; 21(2):209-212. PubMed ID: 32361816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology and genetics of pituitary adenomas.
    Daly AF; Tichomirowa MA; Beckers A
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):543-54. PubMed ID: 19945022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete evaluation of pituitary tumours in a single tertiary care institution.
    Askitis D; Tsitlakidis D; Müller N; Waschke A; Wolf G; Müller UA; Kloos C
    Endocrine; 2018 May; 60(2):255-262. PubMed ID: 29532430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.